The company is addressing significant quality and compliance issues at a key manufacturing site, which has already had a negative financial impact ('Indore Impact').
Filing excerpt
Operational Resilience: Viatris made substantial progress on its initial remediation activities at its oral finished dose manufacturing facility in Indore, India, including but not limited to related personnel actions.
What this signalsFilings often name leadership changes, deals and spending plans.
Competitors
Regions named
sec-10kqualityIssueGet every 10-K signal for Viatris and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Viatris this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/ddd61b5d-4d50-4026-8712-1f2713d0c8bd returns this record as JSON. POST /v1/companies/enrich returns every signal for viatris.com.
{
"signal_id": "ddd61b5d-4d50-4026-8712-1f2713d0c8bd",
"signal_type": "sec-10k",
"signal_subtype": "qualityIssue",
"detected_at": "2026-03-03T06:02:41.098+00:00",
"company": {
"name": "Viatris",
"domain": "viatris.com"
},
"data": {
"detail": "The company is addressing significant quality and compliance issues at a key manufacturing site, which has already had a negative financial impact ('Indore Impact'). This creates an urgent need for quality management systems (QMS), compliance consulting, and operational resilience solutions to satisfy FDA requirements.",
"metrics": {
"timeframe": "current_year"
},
"summary": "Viatris conducting remediation at Indore, India facility following FDA warning letter and import alert.",
"excerpts": "Operational Resilience: Viatris made substantial progress on its initial remediation activities at its oral finished dose manufacturing facility in Indore, India, including but not limited to related personnel actions.",
"relevance": 0.9,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1792044/000179204426000013/vtrs-20251231.htm",
"filing_date": "2026-02-26",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "Quality management needed",
"signal_category": "operations",
"regions_mentioned": [
"India"
],
"competitors_mentioned": [
"Teva Pharmaceutical Industries Ltd."
]
}
}
curl https://signals.autobound.ai/v1/signals/ddd61b5d-4d50-4026-8712-1f2713d0c8bd \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"viatris.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.